| scholarly article | Q13442814 |
| P356 | DOI | 10.2165/00044011-200727010-00004 |
| P698 | PubMed publication ID | 17177579 |
| P2093 | author name string | E Colombo | |
| S Cella | |||
| S Quaranta | |||
| M A Buscaglia | |||
| M G Meroni | |||
| P2860 | cites work | Dopamine as a Prolactin (PRL) Inhibitor | Q22241665 |
| Synchronicity of frequently sampled, 24-h concentrations of circulating leptin, luteinizing hormone, and estradiol in healthy women. | Q30454422 | ||
| Melatonin in psychiatric disorders: a review on the melatonin involvement in psychiatry | Q31805313 | ||
| The diagnosis of premenstrual syndromes and premenstrual dysphoric disorder--clinical procedures and research perspectives | Q33985199 | ||
| Biorhythms and possible central regulation of magnesium status, phototherapy, darkness therapy and chronopathological forms of magnesium depletion | Q34130155 | ||
| Chronopathological forms of magnesium depletion with hypofunction or with hyperfunction of the biological clock | Q34183526 | ||
| Chronobiological basis of female-specific mood disorders | Q34420733 | ||
| Magnesium (mg) retention and mood effects after intravenous mg infusion in premenstrual dysphoric disorder | Q34789978 | ||
| Factor structure of the Modified Moos Menstrual Distress Questionnaire: assessment of prospectively reported follicular, menstrual and premenstrual symptomatology | Q35570556 | ||
| Premenstrual Dysphoric Disorder: Recognition and Treatment | Q35779791 | ||
| What is this PMS? | Q35985308 | ||
| Premenstrual disorders: prevalence, etiology and impact | Q36492286 | ||
| Gonadal hormones and antihormones, serotonin and mood | Q38022655 | ||
| A synergistic effect of a daily supplement for 1 month of 200 mg magnesium plus 50 mg vitamin B6 for the relief of anxiety-related premenstrual symptoms: a randomized, double-blind, crossover study | Q39431508 | ||
| The epidemiology and social impact of premenstrual symptoms | Q39662318 | ||
| Altered serotonergic activity in women with dysphoric premenstrual syndromes | Q40918717 | ||
| Altered waveform of plasma nocturnal melatonin secretion in premenstrual depression | Q46531758 | ||
| Blunted phase-shift responses to morning bright light in premenstrual dysphoric disorder | Q46653580 | ||
| Effects of sex steroid hormones on the neuroendocrine system | Q47790882 | ||
| Nutritional factors in the etiology of the premenstrual tension syndromes | Q49108847 | ||
| Luteal-phase estradiol relates to symptom severity in patients with premenstrual syndrome. | Q50882535 | ||
| Diurnal rhythm of 17 beta-estradiol secretion throughout pubertal development in healthy girls: evaluation by a sensitive radioimmunoassay. | Q50991450 | ||
| Negative mood changes during hormone replacement therapy: a comparison between two progestogens. | Q51072055 | ||
| Plasma melatonin circadian rhythms during the menstrual cycle and after light therapy in premenstrual dysphoric disorder and normal control subjects. | Q51106190 | ||
| The development of a menstrual distress questionnaire. | Q51337922 | ||
| Magnesium measures across the menstrual cycle in premenstrual syndrome. | Q52026873 | ||
| Magnesium Supplementation Alleviates Premenstrual Symptoms of Fluid Retention | Q60567953 | ||
| Premenstrual increase of intracellular magnesium levels in women with ovulatory, asymptomatic menstrual cycles | Q61855265 | ||
| Urinary magnesium in early postmenopausal women. Influence of hormone therapy on calcium | Q67887553 | ||
| The temporal relationship between melatonin and prolactin in women | Q69129861 | ||
| Magnesium and zinc status during the menstrual cycle | Q69437198 | ||
| The effects of norethisterone in postmenopausal women on oestrogen replacement therapy: a model for the premenstrual syndrome | Q69715076 | ||
| Serum ionized magnesium and calcium and sex hormones in healthy young men: importance of serum progesterone level | Q73180909 | ||
| Diurnal rhythms of luteinizing hormone, follicle-stimulating hormone, testosterone, and estradiol secretion before the onset of female puberty in short children | Q73555579 | ||
| Serum ionized magnesium and calcium in women after menopause: inverse relation of estrogen with ionized magnesium | Q77408746 | ||
| Characteristics of placebo responses in medical treatment of premenstrual syndrome | Q78254935 | ||
| P433 | issue | 1 | |
| P921 | main subject | premenstrual syndrome | Q220193 |
| P304 | page(s) | 51-58 | |
| P577 | publication date | 2007-01-01 | |
| P1433 | published in | Clinical Drug Investigation | Q15753215 |
| P1476 | title | Pilot study of the efficacy and safety of a modified-release magnesium 250 mg tablet (Sincromag) for the treatment of premenstrual syndrome | |
| P478 | volume | 27 |
| Q34164399 | Effects of magnesium and vitamin b6 on the severity of premenstrual syndrome symptoms |
| Q35529861 | Evaluating the effect of magnesium and magnesium plus vitamin B6 supplement on the severity of premenstrual syndrome |
| Q36830794 | Intake of selected minerals and risk of premenstrual syndrome |
| Q33749162 | The Effects of Magnesium Supplementation on Subjective Anxiety and Stress-A Systematic Review |
Search more.